VTE Prophylaxis Across the Continuum of Care: High Risk Patients at Hospital Discharge
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 2,500
- 主要终点
- Symptomatic PE/DVT within 90 days of hospital discharge.
研究概览
简要总结
An investigator initiated study exploring VTE prophylaxis at the time of hospital discharge.
详细描述
It appears likely that many patients will remain at risk for VTE at the time of hospital discharge. These risks will go unrecognized, and discharge prophylaxis orders will not be prescribed.
To test this hypothesis, we will perform a retrospective review of approximately 2,500 patients at Brigham and Women's Hospital at risk for VTE at the time of hospital discharge to determine what proportion received VTE prophylaxis. We will correlate the implementation of discharge VTE prophylaxis with the occurrence of symptomatic DVT and pulmonary embolism within 90 days of hospital discharge.
We will also conduct a substudy of this patient population to determine adherence to VTE prophylaxis among hospitalized patients.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 17 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Acutely ill medical and surgical patients with a risk score of 4 or greater without prophylaxis or a risk score of 4 or greater with anticoagulation at hospital discharge.
排除标准
- 未提供
结局指标
主要结局
Symptomatic PE/DVT within 90 days of hospital discharge.
时间窗: 90 days
次要结局
未报告次要终点
研究者
Samuel Z.Goldhaber, MD
Director, VTE Research Group
Brigham and Women's Hospital